Skip to main content
Clinical Trials/IRCT20200823048495N1
IRCT20200823048495N1
Completed
Phase 1

The Effectiveness of Integrative Treatment Interventions on Covid-19 Patients: A Single Group, Pretest-Posttest clinical Trial

Knowledge Research and Innovation Center, Pakistan (KRIC)0 sites39 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
SARS-COV-2.
Sponsor
Knowledge Research and Innovation Center, Pakistan (KRIC)
Enrollment
39
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Knowledge Research and Innovation Center, Pakistan (KRIC)

Eligibility Criteria

Inclusion Criteria

  • Both genders
  • Aged between 18\-80 years
  • Mild, moderate or severe infection
  • COVID\-19 positive on the basis of symptoms, physical test and lab test

Exclusion Criteria

  • Any tumor or malignancy
  • Recent surgery
  • Patient on invasive / non\-invasive ventilator (critical)
  • Taking any other medicine parallel to PAK\-20, Oniater and Hing for treatment of COVID\-19\.
  • Taking any immunosuppressant

Outcomes

Primary Outcomes

Not specified

Similar Trials